Analyst Ratings For Celgene (NASDAQ:CELG)
Today, Stifel Nicolaus reiterated its Buy rating on Celgene (NASDAQ:CELG) with a price target of $128.00.
Some recent analyst ratings include
- 2/28/2018-Stifel Nicolaus Reiterated Rating of Buy .
- 2/28/2018-SunTrust Banks was Downgraded by analysts at SunTrust Banks from a “Buy ” rating to a ” Hold” rating. They now have a $106.00 price target on the stock, up previously from $139.00 .
- 2/15/2018-Cann Reiterated Rating of Buy.
- 2/13/2018-Barclays Upgrade from a “Equal Weight ” rating to a ” Overweight” rating.
- 2/4/2018-Mizuho Reiterated Rating of Buy.
- 1/24/2018-BMO Capital Markets Reiterated Rating of Buy.
Recent Insider Trading Activity For Celgene (NASDAQ:CELG)
Celgene (NASDAQ:CELG) has insider ownership of 0.95% and institutional ownership of 77.84%.
- On 2/23/2018 Ernest Mario, Director, sold 13,370 with an average share price of $94.49 per share and the total transaction amounting to $1,263,331.30.
- On 2/20/2018 Gilla Kaplan, Director, sold 9,250 with an average share price of $94.83 per share and the total transaction amounting to $877,177.50.
- On 2/15/2018 Gilla Kaplan, Director, sold 9,250 with an average share price of $95.99 per share and the total transaction amounting to $887,907.50.
- On 2/8/2018 Mark J Alles, Insider, bought 3,260 with an average share price of $91.90 per share and the total transaction amounting to $299,594.00.
- On 9/25/2017 Terrie Curran, Insider, sold 1,727 with an average share price of $143.89 per share and the total transaction amounting to $248,498.03.
- On 9/12/2017 Gilla Kaplan, Director, sold 9,250 with an average share price of $141.56 per share and the total transaction amounting to $1,309,430.00.
- On 9/5/2017 Michael D Casey, Director, sold 9,250 with an average share price of $139.03 per share and the total transaction amounting to $1,286,027.50.
Recent Trading Activity for Celgene (NASDAQ:CELG)
Shares of Celgene closed the previous trading session at 89.14 down -6.64 6.93% with shares trading hands.